The clinical value of patient-derived glioblastoma tumorspheres in predicting treatment response.

MLA

D’Alessandris, Quintino Giorgio, et al. “The Clinical Value of Patient-Derived Glioblastoma Tumorspheres in Predicting Treatment Response.” Neuro-Oncology, vol. 19, no. 8, Aug. 2017, pp. 1097–108. EBSCOhost, https://doi.org/10.1093/neuonc/now304.

APA

D’Alessandris, Q. G., Biffoni, M., Martini, M., Runci, D., Buccarelli, M., Cenci, T., Signore, M., Stancato, L., Olivi, A., De Maria, R., Larocca, L. M., Ricci-Vitiani, L., & Pallini, R. (2017). The clinical value of patient-derived glioblastoma tumorspheres in predicting treatment response. Neuro-Oncology, 19(8), 1097–1108. https://doi.org/10.1093/neuonc/now304

Chicago

D’Alessandris, Quintino Giorgio, Mauro Biffoni, Maurizio Martini, Daniele Runci, Mariachiara Buccarelli, Tonia Cenci, Michele Signore, et al. 2017. “The Clinical Value of Patient-Derived Glioblastoma Tumorspheres in Predicting Treatment Response.” Neuro-Oncology 19 (8): 1097–1108. doi:10.1093/neuonc/now304.